1024. Impact of Treatment Adherence on Efficacy of DTG/3TC and DTG + TDF/FTC: Pooled Analysis of the GEMINI 1 and 2 Clinical Trials
Mounir Ait‐Khaled(ViiV Healthcare (United Kingdom)), Hung‐Chin Tsai(Kaohsiung Veterans General Hospital), Juan G. Sierra Madero(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Richard Grove(GlaxoSmithKline (United Kingdom)), Rimgaile Urbaityte, Jörg Sievers(ViiV Healthcare (United Kingdom)), Jean A van Wyk(ViiV Healthcare (United Kingdom)), Brian Wynne(Research Triangle Park Foundation), Choy Man, Andrew Zolopa(Palo Alto University), Vicente Estrada(Instituto de Salud Carlos III), Debbie Hagins(Coastal Health District), Roberto Gulminetti(University of Pavia)
Cited by 1